Key result
Incidental pulmonary embolism in cancer patients was associated with a significantly higher risk of long-term all-cause mortality (HR 2.26) compared to those without incidental pulmonary embolism.
Why the study?
The effect of incidental pulmonary embolism on long-term prognosis in cancer patients is unclear.
Does incidental pulmonary embolism increase long-term mortality in cancer patients?
Comparison
Incidental PE (PE+ group) vs no PE (PE- group)
Design
Single-center retrospective cohort study
Authors
Loading...
Incidental PE in cancer patients needs cautious prognostic interpretation; leaves open independent survival impact pending prospective data.
Cohort (n=13,371)
No
Does incidental pulmonary embolism increase long-term mortality in cancer patients?
Hazard Ratio: 2.26 (95% CI 1.53–3.33)
p-value: p=<0.001
Incidental pulmonary embolism in cancer patients is associated with a more than two-fold increased risk of long-term all-cause mortality, driven primarily by cancer-related rather than thrombosis-related factors.
Nishikawa et al. (2021) conducted a cohort in Cancer (n=13,371). Incidental pulmonary embolism vs. No incidental pulmonary embolism was evaluated on Long-term all-cause mortality (HR 2.26, 95% CI 1.53-3.33, p=<0.001). Incidental pulmonary embolism in cancer patients was associated with a significantly higher risk of long-term all-cause mortality (HR 2.26) compared to those without incidental pulmonary embolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: